{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T06:34:29Z","timestamp":1747204469705,"version":"3.40.5"},"posted":{"date-parts":[[2023,1,13]]},"group-title":"In Review","reference-count":29,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2023,1,13]],"date-time":"2023-01-13T00:00:00Z","timestamp":1673568000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2022,12,18]]},"abstract":"<title>Abstract<\/title>\n        <p>Background\n Both pulmonary tuberculosis (PTB) and chronic pulmonary aspergillosis (CPA) significantly affect health-related quality of life (HR-QoL). We aimed to determine the impact of CPA co-infection on the HR-QoL of Ugandans with PTB.\nMethods\n  We conducted a prospective study among participants with PTB with persistent pulmonary symptoms after 2 months of anti-TB treatment at Mulago Hospital, Kampala, Uganda between July 2020 and June 2021. HR-QoL was assessed using St. George Respiratory Questionnaire (SGRQ) at enrollment and at the end of PTB treatment (4 months apart). SGRQ scores range from 0 to 100, with higher score representing a poorer HR-QoL.\nResults\n Of the 162 participants enrolled, 32 (19.8%) had CPA\u2009+\u2009PTB and 130 (80.2%) had PTB only. The baseline characteristics of the two groups were comparable. Regarding overall health, a higher proportion of the PTB only group rated their HR-QoL as \u201cvery good\u201d compared to those who had both TB and CPA (68 (54.0%) <italic>versus<\/italic> 8 (25.8%)). At enrollment, both groups had comparable median SGRQ scores. However, at follow up, the PTB only group had statistically significantly better SGRQ scores (interquartile range); symptoms (0 (0 \u2014 12.4) <italic>versus<\/italic> 14.4 (0 \u2014 42.9), p\u2009&lt;\u20090.001), activity ((0 (0 \u2014 17.1) <italic>versus<\/italic> 12.2 (0 \u2014 35.5), p\u2009=\u2009.03), impact (0 (0 \u2014 4.0) <italic>versus<\/italic> 3.1 (0 \u2014 22.5), p\u2009=\u20090.004), and total scores ((0 (0 \u2014 8.5) <italic>versus<\/italic> 7.6 (0 \u2014 27.4), p\u2009=\u20090.005).\nConclusion\n CPA co-infection impairs HR-QoL of people with PTB. Active screening and management of CPA in patients with PTB is recommended to improve HR-QoL of these individuals.<\/p>","DOI":"10.21203\/rs.3.rs-2389854\/v1","type":"posted-content","created":{"date-parts":[[2023,1,13]],"date-time":"2023-01-13T18:01:32Z","timestamp":1673632892000},"source":"Crossref","is-referenced-by-count":0,"title":["The Impact of Chronic Pulmonary Aspergillosis Co-infection on the Health-Related Quality of Life of Patients with Pulmonary Tuberculosis in Uganda"],"prefix":"10.21203","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1578-0770","authenticated-orcid":false,"given":"Martha","family":"Namusobya","sequence":"first","affiliation":[{"name":"Makerere University CHS: Makerere University College of Health Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felix","family":"Bongomin","sequence":"additional","affiliation":[{"name":"Gulu University Faculty of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Mukisa","sequence":"additional","affiliation":[{"name":"Makerere University Faculty of Medicine: Makerere University College of Health Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles","family":"Batte","sequence":"additional","affiliation":[{"name":"Makerere University Faculty of Medicine: Makerere University College of Health Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William Kane","family":"Olwit","sequence":"additional","affiliation":[{"name":"Makerere University Medical School: Makerere University College of Health Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua","family":"Rhein","sequence":"additional","affiliation":[{"name":"University of Minnesota Department of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Sekaggya-Wiltshire","sequence":"additional","affiliation":[{"name":"Makerere University Infectious Diseases Institute"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shailendra","family":"Prasad","sequence":"additional","affiliation":[{"name":"University of Minnesota Department of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3329\/jhpn.v28i2.4879","article-title":"Tuberculosis: A Global Health Problem","volume":"28","author":"Zaman K","year":"2010","unstructured":"Zaman K. 2010. Tuberculosis: A Global Health Problem. J Health Popul Nutr 28. doi:10.3329\/jhpn.v28i2.4879.","journal-title":"J Health Popul Nutr"},{"year":"2018","author":"Ravimohan S","key":"ref2","unstructured":"Ravimohan S, Kornfield H, Weissman D, Bisson GP. Tuberculosis and lung damage: from epidemiology to pathophysiology. Eur Respir Rev. 2018 Mar 31;27 (147)."},{"issue":"10","key":"ref3","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/S1473-3099(19)30309-3","article-title":"Long-term all-cause mortality in people treated for tuberculosis: a systematic review and meta-analysis","volume":"19","author":"Romanowski K","year":"2019","unstructured":"Romanowski K, Baumann B, Basham CA, Ahmad Khan F, Fox GJ, Johnston JC. Long-term all-cause mortality in people treated for tuberculosis: a systematic review and meta-analysis. Lancet Infect Dis. 2019 Oct;19(10):1129\u201337.","journal-title":"Lancet Infect Dis"},{"year":"2020","author":"Visca D","key":"ref4","unstructured":"Visca D, Centis R, Munoz-Torrico M, Pontali E. Post-tuberculosis sequalae: the need to look beyond treatment outcome. Int J Tuberc Lung Dis. 2020 Aug 1;24(8):761-2."},{"issue":"4","key":"ref5","doi-asserted-by":"crossref","first-page":"e0174605","DOI":"10.1371\/journal.pone.0174605","article-title":"Health-related quality of life in South African patients with pulmonary tuberculosis","volume":"12","author":"Kastien-Hilka T","year":"2017","unstructured":"Kastien-Hilka T, Rosenkranz B, Sinanovic E, Bennett B, Schwenkglenks M. Health-related quality of life in South African patients with pulmonary tuberculosis. PLoS ONE. 2017;12(4):e0174605.","journal-title":"PLoS ONE"},{"issue":"5","key":"ref6","doi-asserted-by":"crossref","first-page":"e0151892","DOI":"10.1371\/journal.pone.0151892","article-title":"Change in Health-Related Quality of Life among Pulmonary Tuberculosis Patients at Primary Health Care Settings in South Africa: A Prospective Cohort Study","volume":"11","author":"Louw JS","year":"2016","unstructured":"Louw JS, Mabaso M, Peltzer K. Change in Health-Related Quality of Life among Pulmonary Tuberculosis Patients at Primary Health Care Settings in South Africa: A Prospective Cohort Study. PLoS ONE. 2016;11(5):e0151892.","journal-title":"PLoS ONE"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7525-8-93","author":"Babikako H","year":"2010","unstructured":"Babikako H, Neuhauser D, Katamba A, Mupere E. (2010). Feasibility, reliability and validity of health-related quality of life questionnaire among adult pulmonary tuberculosis patients in urban Uganda: Cross-sectional study. Health and quality of life outcomes. 8. 93. 10.1186\/1477-7525-8-93."},{"author":"Gayozo Diz P","key":"ref8","unstructured":"Gayozo Diz P. Commentary: Importance of health-related quality of life in primary care. Primary Care Vol.31 Issue 5. Pg 293\u2013294. March 2003."},{"key":"ref9","volume":"31","author":"Health-related quality of life","year":"2018","unstructured":"Health-related quality of life. Centre for Disease Control. Oct.31 2018.","journal-title":"Centre for Disease Control. Oct"},{"issue":"12","key":"ref10","doi-asserted-by":"crossref","first-page":"864","DOI":"10.2471\/BLT.11.089441","article-title":"Global burden of chronic pulmonary aspergillosis as a sequel to pulmonary tuberculosis","volume":"89","author":"Denning DW","year":"2011","unstructured":"Denning DW, Pleuvry A, Cole DC. Global burden of chronic pulmonary aspergillosis as a sequel to pulmonary tuberculosis. Bull World Health Organ. 2011;89(12):864\u201372.","journal-title":"Bull World Health Organ"},{"key":"ref11","unstructured":"WHO. Tuberculosis survivors at risk of fungal infection. Accessed online: http:\/\/wwwwhoint\/bulletin\/releases\/NFM1211ENpdf. 2011."},{"year":"2015","author":"Iain D","key":"ref12","unstructured":"Iain D. Page; William Worodria; Alfred Andama; Irene Ayakaka RKLDLHMRDWD. Aspergillus co-infection may be common in Africans with active pulmonary tuberculosis. A thesis submitted to the University of Manchester for the degree of Doctor of Philosophy (PhD). 2015."},{"issue":"6","key":"ref13","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/myc.13444","article-title":"Chronic pulmonary aspergillosis in patients with active pulmonary tuberculosis with persisting symptoms in Uganda","volume":"65","author":"Namusobya M","year":"2022","unstructured":"Namusobya M, Bongomin F, Mukisa J, Olwit WK, Batte C, Mukashyaka C, Mande E, Kwizera R, Denning DW, Rhein J, Prasad S, Sekaggya-Wiltshire C. Chronic pulmonary aspergillosis in patients with active pulmonary tuberculosis with persisting symptoms in Uganda. Mycoses. 2022 Jun;65(6):625\u201334. doi: 10.1111\/myc.13444. Epub 2022 Apr 24. PMID: 35419885; PMCID: PMC9156563.","journal-title":"Mycoses"},{"issue":"6","key":"ref14","first-page":"1321","article-title":"A self-complete measure of health status for chronic airflow limitation. The St. George\u2019s Respiratory questionnaire.Am Rev Respir Dis","volume":"145","author":"Jones PW","year":"1992","unstructured":"Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A self-complete measure of health status for chronic airflow limitation. The St. George\u2019s Respiratory questionnaire.Am Rev Respir Dis. 1992 Jun; 145(6):1321\u20137."},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2019.02.039","article-title":"Kempker. Pulmonary function and respiratory health after successful treatment of drug-resistant tuberculosis","author":"Sergo A","unstructured":"Sergo A, Vashakidze JA, Kempker NA, Jakobia, Shota G, Gogishvili KA, Nikolaishvili LM, Goginashvili MJ, Magee, Russell R. Kempker. Pulmonary function and respiratory health after successful treatment of drug-resistant tuberculosis.<uvertical-align:super;> <\/uvertical-align:super;><background-color:#CCFF99;uvertical-align:super;>Int J Infect Dis. 2019<\/background-color:#CCFF99;uvertical-align:super;><uvertical-align:super;> <\/uvertical-align:super;><uvertical-align:super;>May<\/uvertical-align:super;><uvertical-align:super;>;<\/uvertical-align:super;><uvertical-align:super;> <\/uvertical-align:super;><background-color:#FFCC66;uvertical-align:super;>82<\/background-color:#FFCC66;uvertical-align:super;><uvertical-align:super;>:<\/uvertical-align:super;><uvertical-align:super;> <\/uvertical-align:super;><background-color:#D279FF;uvertical-align:super;>66\u201372<\/background-color:#D279FF;uvertical-align:super;><uvertical-align:super;>.<\/uvertical-align:super;> Published online 2019 Mar 5. doi: 10.1016\/j.ijid.2019.02.039."},{"author":"Bongomin F","key":"ref16","doi-asserted-by":"publisher","unstructured":"Bongomin F, Harris C, Hayes G, Kosmidis C, Denning DW. Twelve-month clinical outcomes of 206 patients with chronic pulmonary aspergillosis. PLoS One. 2018 Apr 10;13(4):e0193732. doi: 10.1371\/journal.pone.0193732. PMID: 29634721; PMCID: PMC5892866.","DOI":"10.1371\/journal.pone.0193732"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"204993612110346","DOI":"10.1177\/20499361211034643","article-title":"Utility of St. George\u2019s respiratory questionnaire in predicting clinical recurrence in chronic pulmonary aspergillosis","volume":"8","author":"Bongomin F","year":"2021","unstructured":"Bongomin F, Otu A. Utility of St. George\u2019s respiratory questionnaire in predicting clinical recurrence in chronic pulmonary aspergillosis. Therapeutic Adv Infect Disease. 2021;8:204993612110346. doi:10.1177\/20499361211034643.","journal-title":"Therapeutic Adv Infect Disease"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1093\/mmy\/myaa026","author":"Bongomin F","year":"2020","unstructured":"Bongomin F, Garcez T, Denning DW. Impact of high baseline Aspergillus-specific IgG levels on weight and quality-of-life outcomes of patients with chronic pulmonary aspergillosis. Med Mycol. 2020 Oct 1;58(7):1000\u20131004. doi: 10.1093\/mmy\/myaa026. PMID: 32343313."},{"author":"Morgan BW","key":"ref19","doi-asserted-by":"publisher","unstructured":"Morgan BW, Grigsby MR, Siddharthan T, Kalyesubula R, Wise RA, Hurst JR, Kirenga B, Checkley W. Validation of the Saint George's Respiratory Questionnaire in Uganda. BMJ Open Respir Res. 2018 Jul 11;5(1):e000276. doi: 10.1136\/bmjresp-2018-000276. PMID: 30018764; PMCID: PMC6045769.","DOI":"10.1136\/bmjresp-2018-000276"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1183\/09031936.02.00063702","article-title":"Interpreting thresholds for a clinically significant change in health status in asthma and COPD","volume":"19","author":"Jones PW","year":"2002","unstructured":"Jones PW. Interpreting thresholds for a clinically significant change in health status in asthma and COPD. Eur Respir J. 2002;19:398\u2013404. doi:10.1183\/09031936.02.00063702.","journal-title":"Eur Respir J"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/s0954-6111(06)80166-6","author":"Jones PW","year":"1991","unstructured":"Jones PW, Quirk FH, Baveystock CM. The St George's Respiratory Questionnaire. Respir Med. 1991 Sep;85 Suppl B:25\u201331; discussion 33 \u2013 7. doi: 10.1016\/s0954-6111(06)80166-6. PMID: 1759018."},{"key":"ref22","volume-title":"June). The St George's Respiratory Questionnaire manual","author":"Jones P","year":"2009","unstructured":"Jones P. June). The St George's Respiratory Questionnaire manual. London, UK; St George\u2019s, University of London; 2009."},{"key":"ref23","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1477-7525-7-14","article-title":"Measuring health-related quality of life in tuberculosis: a systematic review","volume":"18","author":"Guo N","unstructured":"Guo N, Marra F, Marra CA. Measuring health-related quality of life in tuberculosis: a systematic review. Health Qual Life Outcomes. 2009 Feb 18;7:14. doi: 10.1186\/1477-7525-7-14. PMID: 19224645; PMCID: PMC2651863.","journal-title":"Health Qual Life Outcomes. 2009 Feb"},{"author":"Adeyeye OO","key":"ref24","doi-asserted-by":"publisher","unstructured":"Adeyeye OO, Ogunleye OO, Coker A, Kuyinu Y, Bamisile RT, Ekrikpo U, Onadeko B. Factors Influencing Quality of Life and Predictors of Low Quality of Life Scores in Patients on Treatment for Pulmonary Tuberculosis: A Cross Sectional Study. J Public Health Afr. 2014 Dec 18;5(2):366. doi: 10.4081\/jphia.2014.366. PMID: 28299129; PMCID: PMC5345416.","DOI":"10.4081\/jphia.2014.366"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"790134","DOI":"10.3389\/fcimb.2022.790134","article-title":"Prospective Evaluation of Positivity Rates of Aspergillus-Specific IgG and Quality of Life in HIV-Negative Tuberculosis Patients in Lagos, Nigeria","volume":"3","author":"Oladele RO","unstructured":"Oladele RO, Gbajabimiala T, Irurhe N, Skevington SM, Denning DW. Prospective Evaluation of Positivity Rates of Aspergillus-Specific IgG and Quality of Life in HIV-Negative Tuberculosis Patients in Lagos, Nigeria. Front Cell Infect Microbiol. 2022 Feb 3;12:790134. doi: 10.3389\/fcimb.2022.790134. PMID: 35186788; PMCID: PMC8851390.","journal-title":"Front Cell Infect Microbiol. 2022 Feb"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"100121","DOI":"10.1016\/j.jctube.2019.100121","article-title":"Quality of life with tuberculosis","volume":"17","author":"Aggarwal AN","year":"2019","unstructured":"Aggarwal AN. Quality of life with tuberculosis. J Clin Tuberc Other Mycobact Dis. 2019;17:100121. doi:10.1016\/j.jctube.2019.100121. Published 2019 Sep 20.","journal-title":"J Clin Tuberc Other Mycobact Dis"},{"issue":"3","key":"ref27","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1177\/1010539509336242","article-title":"Gopal Krishan Ingle. A study of the impact of tuberculosis on the quality of life and the effect after treatment with DOTS","volume":"21","author":"Dhuria M","unstructured":"Dhuria M, Sharma N, Singh NP, Jiloha RC, Saha R. Gopal Krishan Ingle. A study of the impact of tuberculosis on the quality of life and the effect after treatment with DOTS. Asia Pac J Public Health. 2009 Jul;21(3):312\u201320. doi: 10.1177\/1010539509336242. Epub 2009 May 14. PMID: 19443879.","journal-title":"Asia Pac J Public Health. 2009"},{"issue":"3\u20134","key":"ref28","first-page":"71","article-title":"Study of impact of antitubercular therapy on quality of life","volume":"66","author":"Balgude A","unstructured":"Balgude A, Sontakke S. Study of impact of antitubercular therapy on quality of life. Indian J Med Sci. 2012 Mar-Apr;66(3\u20134):71\u20137. PMID: 23603624.","journal-title":"Indian J Med Sci. 2012 Mar-Apr"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.5588\/ijtld.12.0299","author":"Aggarwal AN","year":"2013","unstructured":"Aggarwal AN, Gupta D, Janmeja AK, Jindal SK. Assessment of health-related quality of life in patients with pulmonary tuberculosis under programme conditions. Int J Tuberc Lung Dis. 2013 Jul;17(7):947 \u2013 53. doi: 10.5588\/ijtld.12.0299. PMID: 23743314."}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-2389854\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-2389854\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T01:35:16Z","timestamp":1697506516000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-2389854\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,13]]},"references-count":29,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-2389854\/v1","relation":{"is-preprint-of":[{"id-type":"doi","id":"10.1007\/s11046-023-00741-1","asserted-by":"subject"}]},"subject":[],"published":{"date-parts":[[2023,1,13]]},"subtype":"preprint"}}